UP!

ECT $0.4

ECT target price
0.40
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

9369-03-21
6844-02-14
6507-04-02
6504-03-19
4002-02-26
3679-03-31
2222-03-09
2015-09-01 Downgrade Raymond James Market Perform to Underperform
2014-01-09 Downgrade Raymond James Outperform to Market Perform
2013-11-22 Upgrade Raymond James Market Perform to Outperform
2012-03-13 Reiterated Robert W. Baird Underperform $17 to $15
2012-01-11 Reiterated Robert W. Baird Underperform $15 to $17
2012-01-09 Downgrade Oppenheimer Perform to Underperform $20
2011-05-17 Downgrade Oppenheimer Outperform to Perform
2011-02-08 Initiated Robert W. Baird Neutral $30
2010-12-15 Reiterated Oppenheimer Outperform $26 to $30
2010-10-21 Reiterated Oppenheimer Outperform $23 to $26
2010-09-29 Initiated Oppenheimer Outperform $23
1970-01-01
9369-03-21
6844-02-14
6507-04-02
6504-03-19
4002-02-26

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In ECT 0 funds of 2213 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks